White House insists GOP health-care bill will pass ahead of tight vote

On Thursday afternoon, the conservative House Freedom Caucus announced it had not reached a deal in discussions with President Trump over the American Health Care Act, the Republican health-care bill that is expected to be put to a floor vote Thursday night. Losing the support of the conservative caucus narrows the bill's chances of passage considerably: Republican leadership cannot lose more than 22 Republican votes and still pass the bill through the lower chamber, but roughly two dozen Freedom Caucus members have said they would not support the plan. At the time of publication, NBC News' tally had a total of 31 "nos" from Republican congressmen.
"Something seismic would have to happen in the next few hours to turn this bill around," Politico estimates. "At this point, if a deal emerged, it would be very late tonight. In the midnight hour, perhaps."
But when questioned about the bill Thursday, White House Press Secretary Sean Spicer insisted it would pass. "We continue to see the number [of Freedom Caucus members who support the bill] go up, not down, and that's a very positive sign," he said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"We continue to see the number go up and not down," Spicer says on House Freedom Caucus support of health care bill https://t.co/T5uqoA85rO pic.twitter.com/0ULpLMBAlO— CBS News (@CBSNews) March 23, 2017
The same cannot be said for American voters, a new Quinnipiac poll of 1,056 voters found. Fifty-six percent of American voters disapproved of the ObamaCare replacement, the poll found, while just 17 percent supported it. The poll has a margin of error of plus or minus 3 percentage points.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Jeva Lange was the executive editor at TheWeek.com. She formerly served as The Week's deputy editor and culture critic. She is also a contributor to Screen Slate, and her writing has appeared in The New York Daily News, The Awl, Vice, and Gothamist, among other publications. Jeva lives in New York City. Follow her on Twitter.
-
A wine-themed tour of beautiful Uruguay
The Week Recommends Secret paradise in South America boasts beautiful vineyards
By The Week UK Published
-
Romanian democracy: no place for the 'TikTok messiah' Calin Georgescu
Talking Point State is 'fighting back' against poster boy for right-wing conspiracists
By The Week UK Published
-
5 terrifically taxing cartoons about tariffs
Cartoons Artists take on rising prices, dumb ideas, and more
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published